220 related articles for article (PubMed ID: 30272314)
1. Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
Xu SP; Li YS
Int J Mol Med; 2018 Dec; 42(6):3220-3230. PubMed ID: 30272314
[TBL] [Abstract][Full Text] [Related]
2. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
[TBL] [Abstract][Full Text] [Related]
3. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
4. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
5. Effects of Astragalus membranaceus on systemic lupus erythematosus in a mouse model of pregnancy.
Chen HQ; Zhang N; Li CX; Zhang HX
Immun Inflamm Dis; 2022 Jun; 10(6):e624. PubMed ID: 35634952
[TBL] [Abstract][Full Text] [Related]
6. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
Wang H; Knight JS; Hodgin JB; Wang J; Guo C; Kleiman K; Eitzman DT
Sci Rep; 2016 Jun; 6():28997. PubMed ID: 27357136
[TBL] [Abstract][Full Text] [Related]
7. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
8. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
9. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
[TBL] [Abstract][Full Text] [Related]
10. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Fu D; Senouthai S; Wang J; You Y
BMC Nephrol; 2019 Sep; 20(1):350. PubMed ID: 31488076
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
[TBL] [Abstract][Full Text] [Related]
15. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
16. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Lourenço EV; Wong M; Hahn BH; Palma-Diaz MF; Skaggs BJ
Arthritis Rheumatol; 2014 Mar; 66(3):674-85. PubMed ID: 24574228
[TBL] [Abstract][Full Text] [Related]
17. 3
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Liang J; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
J Immunol Res; 2019; 2019():2431617. PubMed ID: 31240232
[TBL] [Abstract][Full Text] [Related]
18. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
[TBL] [Abstract][Full Text] [Related]
19. Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
Kluger MA; Melderis S; Nosko A; Goerke B; Luig M; Meyer MC; Turner JE; Meyer-Schwesinger C; Wegscheid C; Tiegs G; Stahl RA; Panzer U; Steinmetz OM
Kidney Int; 2016 Jan; 89(1):158-66. PubMed ID: 26466322
[TBL] [Abstract][Full Text] [Related]
20. Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis.
Ijima S; Saito Y; Nagaoka K; Yamamoto S; Sato T; Miura N; Iwamoto T; Miyajima M; Chikenji TS
Front Immunol; 2022; 13():960601. PubMed ID: 36466895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
